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Suppression of the Neutral Protease
Activity of Macrophages Treated with
Asbestos in Vitro
by John A. Hamilton*
Macrophages are often conspicuous in asbestos-induced inflammatory lesions. Chrysotile type B
elicits macrophages into the peritoneal cavity of mice which produce high levels of the neutral pro-
tease, plasminogen activator; in vitro addition of these same fibers to mouse peritoneal macrophages
stimulates enzyme production. It is reported here that, for endotoxin-elicited mouse peritoneal macro-
phages fed chrysotile type B in vitro, the increased plasminogen activator activity is suppressed by
low concentrations of anti-inflammatory steroids. Other active drugs include colchicine and vinblas-
tine. These studies are considered important, as they suggest an approach to controlling the levels
of a potentially deleterious enzyme system (PA-plasmin) from macrophages treated with asbestos
fibers.
Introduction
Asbestosis is characterized by inflammation and
fibrosis surrounding the respiratory bronchioles and
alveoli and leads to permanent impairment of lung
function (1). Macrophages are found in normal alveoli
and are the prominent cell type found in chronic in-
flammatory lesions, including those induced by as-
bestos (2). Macrophages are able to release in vitro a
number of molecules which are probably important
in the initiation and maintenance of an inflammatory
reaction, for example, neutral proteases, comple-
ment components, endogenous pyrogens, oxygen
metabolites, prostaglandins and analogs, prolifera-
tion factors for neighboring cells, etc.(3).
For monocyte macrophages in vitro, the activity
of the neutral protease, plasminogen activator (PA),
shows positive correlations with stimuli [for exam-
ple, asbestos (4), endotoxin (5), lymphokines (6), and
phorbol esters (7,8)] and suppressive drugs [for ex-
ample, glucocorticoids (9)] associated with an inflam-
matory response. A role for macrophage PA activity
in cell migration from blood to tissue and in the pro-
cesses of tissue destruction and activation of several
inflammatory enzyme cascades has previously been
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proposed (9). We have been able to show that IARC
chrysotile type B elicits macrophages into the perito-
neal cavity of mice which produce high levels of PA
(4, 10); in vitro addition of these fibers to mouse
peritoneal macrophages stimulates enzyme produc-
tion.
The present studies indicate that the in vitro
stimulation of macrophage PA activity can be sup-
pressed by anti-inflammatory glucocorticoids and,
under certain culture conditions, by colchicine and
vinblastine.
Materials and Methods
Reagents
Reagents were obtained commercially as follows:
fetal bovine serum (Flow Laboratories, Hamden,
CT); asbestos, IARC chrysotile type B, a gift from
Johns-Manville Corp.; soybean trypsin inhibitor and
bovine fibrinogen; fraction I (Miles Laboratories
Inc., Kankakee, IL) lactalbumin hydrolyzate (Nutri-
tional Biochemicals Corp., Cleveland, OH); poly-
styrene latex particles, 1.01 Mm diameter (Dow Diag-
nostics, Indianapolis, IN); steroids and colchicine
(Sigma Chemical Co., St. Louis, MO); vinblastine (Eli
Lilly and Co., Indianapolis, IN).
All steroids were dissolved at 10-' M in ethanol
and stored at 4°C. Controls for the effect of solvent
never differed from those of other untreated drug-J. A. HAMILTON
free cultures. Plasminogen-free fibrinogen for the
fibrin plates was prepared as before (9). Endotoxin,
S. minnesota lipopolysaccharide, mR595(S418), was a
gift from Dr. 0. Luderitz, Max Planck Insitut fur Im-
munobiologie, Freiburg, West Germany. Human ly-
sozyme was a gift from Dr. E. Osserman (College of
Physicians and Surgeons of Columbia University,
New York).
Stock suspensions of asbestos in PBS and latex
particles in Dulbecco's medium (DB) at 5 x 109 parti-
cles/mL were irradiated with ultraviolet light and
kept at40C until use(4).
Peritoneal Cells
Peritoneal cells were obtained from NCS (Rocke-
feller) mice (25-30 g) or BDF, mice, 8-12 weeks old
(Cumberland Farms), that had been injected intra-
peritoneally 4 days previously with phosphate-buf-
fered saline(PBS), pH 7.4, or with 30,gendotoxin(4).
Fibrinolysis Measurement
The peritoneal cells (2 x 106) were plated on 1II-fi-
brin-coated wells (LinbroDisposoTrays, FB 16-24TC)
(9) for 24 h in DB supplemented with 5% heat-inacti-
vated(560C, 30 min)fetal bovine serum (FBS). At this
stage, soybean trypsin inhibitor (STI) (100 ,ug/mL)
was added to block any fibrinolysis. The cells were
washed twice with PBS and placed again in DB +
5% FBS + STI. The particulate preparations were
resuspended by passage through a syringe and 26G
needle and carefully distributed in the culture medi-
um. The particles were generally added for 2 hr,
after which time >95% of the cells contained 20-50
latex particles. The macrophages were then washed
three times with PBS and placed in DB + 5% acid-
treated FBS (ATFBS) for assay. The acid treatment
removes interfering protease inhibitors (9). Fibrino-
lysis was estimated' by withdrawingaliquots ofmedi-
um and counting the radioactivity in a Packard
Autogamma scintillation spectrometer. The plas-
minogen dependence of the fibrinolytic activity can
be shown by assaying in the presence of ATFBS
from which the plasminogen has been removed (9).
Measurement of Secreted Plasminogen
Activator
Peritoneal cells(2 x 106) were plated in DB + 5%
FBS on regular linbro trays. At 24 hr after plating,
the cells were washed twice with PBS and placed
again in DB + 5% FBS but also in the presence of
the particles for an additional 24 hr. After this
period, the cultures were washed twice with PBS
and placed in DB containing 0.05% lactalbumin hy-
drolyzate (LH) (9). After 24 hr, the serum-free condi-
tioned media (CM) were collected; also, the cells were
washed twice with PBS, lysed by the addition ofTri-
ton X-100 (0.2% v/v in water) and scraped from the
surface of the dish with a plastic policeman for pro-
tein determination.
Serum-free CM were kept frozen at -20°C until
assay for PA activity. For this purpose, 1"I-fibrin-
coated wells ofLinbro Disposo Trays were used, and
the assay mixture contained 2,ug human plasmino-
gen (purified from outdated human plasma) and 10
M.*L CM in 250ML 0.1 M Tris chloride, pH 8.1 (9).
All experiments included appropriate controls for
all reagents and media. No plasminogen-independent
fibrinolysis could be detected when plasminogen was
not included in the assay mixture. One unit of PA is
defined as the amount that stimulates the release of
10% ofthe initialradioactivity in 4 hr(9).
Lysozyme
Lysozyme in serum-free CM was assayed by mea-
suring the initial rate of lysis of a suspension of Mi-
crococcus luteus, as described by Gordon et al. (11).
Human lysozyme diluted in DB + 0.05 % LH was
used as standard.
Lysosomal Enzymes
N-Acetyl-f-D-glucosaminidase and p-galactosidase
were assayed as described by Bowers et al. (12).
Protein
Protein was measured by the method ofLowry et
al.(13) with bovine serum albumin as standard.
Results
Enhanced Macrophage PA Activity after
Asbestos Exposure in Vitro
Phagocytosis ofdigestible and nondigestible mate-
rials enhances the PA activity of mouse peritoneal
macrophages (4, 5). Figure 1 demonstrates that as-
bestos fibers can increase the PA activity of perito-
neal macrophages obtained from endotoxin-injected
mice and also PBS-injected mice as a control popula-
tion. Comparable results were obtained whether the
asbestos addition was allowed for 2 hr or for 24 hr
prior to the PA measurement. For asbestos doses
less than 1001.g,there did not appear to be any gross
alterations in cell morphology, but with 100,g fiber
there was some cell rounding and detachment after
3-4 days. The control, unstimulated peritoneal mac-
rophages released PA activity in the presence ofthe
asbestos, but there was a longer lag period than for
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the endotoxin-induced cells. The fibrinolytic activity
was predominantly (> 95%) plasminogen-dependent,
and hence PA activity was being monitored.
Inhibition of in Vitro-Stimulated
Fibrinolytic Activity with Drugs
If the assumption is correct that the generation of
excessive PA activity around macrophages interact-
ing with asbestos fibers would be deleterious, then it
would be desirable to find drugs which might sup-
press this local proteolysis. In Table 1, a comparison
is made of three steroids for their effect on the as-
bestos-stimulated plasminogen-dependent fibrinoly-
tic activity. The glucocorticoids, dexamethasone and
prednisolone, are effective whereas progesterone is
not. The data using latex feeding to cells are in-
cluded for comparison. This inhibition of the in-
creased fibrinolysis persists for at least 72 hr, the
maximum assay time.
Table 2 lists the relative efficacies of different
steroids. Also included for comparison are colchicine
and vinblastine, drugs implicated in the control of
secretory processes. Certain glucocorticoids are
again effective. It is interesting that the activity pro-
file for the steroids is similar to that found for their
suppression of the PA activity of thioglycollate-in-
duced macrophages (9). Colchicine and vinblastine
had little influence on the cells if plated on "^I-fibrin
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(Table 2) but were quite effective if harvest fluid is
assayed for the PA activity from asbestos-treated
cells (see below). It can be noted that the PA activity
ofthe endotoxin-primed cells themselves was also in-
hibited. From Table 1 and 2, it can be observed that
Table 1. Effect of steroids on the fibrinolytic activity for cells
treated with asbestos in vitro.
Radioactivity
Macrophages released
(8 x 105)a Drug(10-7M) at 24 hr, %
Endotoxin - 8
Dexamethasone 0
Prednisolone 0
Progesterone 6
Endotoxin + asbestos
(100,ug) - 34
Dexamethasone 1
Prednisolone 2
Progesterone 26
Endotoxin + latex - 42
Dexamethasone 6
Prednisolone 7
Progesterone 39
a Peritoneal cells were cultured for 24 hr on '25I fibrin-coated
Linbro wells in the usual manner, before the asbestos or latex
feeding. After washing, the solid particles were added in DB +
5% FBS and 100 pg/mL STI for 2 hr at 370C. After washing to
remove excess particles, DB + 5% ATFBS was added in
presence or absence ofdrug. Samples assayed as in Fig. 1.
,E +O.1umg Asb
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FIGURE 1. Effect of asbestos feeding in vitro on macrophage fibrinolysis. Before the
asbestos feeding, 2 x 106 peritoneal cells were cultured for 24 hr on '25I-fibrin-coated
Linbro wells. The cells were then washed once with PBS, then various quantities of
the solid particles added in 1 mL DB containing 5% FBS and 100pg/mL STI for 2 hr at
37°C, the excess particles removed by washing twice with PBS and then 2 mL of DB
containing 5% ATFBS added. Samples were aliquoted from duplicate cultures and
counted for released radioactivity. (0) endotoxin-stimulated macrophages (E); (V) E fed
0.1 ,ug asbestos (E + 0.1 jg Asb); (A) E fed 1 jg asbestos (E + 1 pg Asb); (0) E fed Mg
asbestos (E + 10mg Asb); (U) E fed 100mg Asb (E + 100 Ag Asb); (V) E fed latex (EL);
(0) unstimulated macrophages (U)(A) U fed 10Mg asbestos(U + 10jAgAsb).
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Table 2. Effect of drugs on the fibrinolytic activity for cells
tested with asbestos in vitro.
Radioactivity
Macrophages released
(8 x 105)a Drug(10- 7M) at 24 hr, %
Endotoxin - 24
Hydrocortisone 8
9-Fluorocortisone 14
Desoxycorticosterone 20
Cortexelone 24
Aldosterone 22
Testosterone 23
P-Estradiol 25
Colchicine 33
Vinblastine 35
Endotoxin - 59
+ 10Q0 g asbestos
Hydrocortisone 21
9-Fluorocortisone 25
Desoxycorticosterone 32
Cortexelone 53
Aldosterone 45
Testosterone 56
P-Estradiol 56
Colchicine 51
Vinblastine 41
Endotoxin + latex - 54
Hydrocortisone 17
9-Fluorocortisone 24
Desoxycorticosterone 31
Cortexelone 51
Aldosterone 44
Testosterone 44
P-Estradiol 48
Colchicine 74
Vinblastine 46
a Same experimental protocol as in Table 1.
there is a comparable effect of the drugs for cells fed
latex particles.
The most potent glucocorticoid tested was dexa-
methasone and, as can be seen from Table 3, it is ef-
fective even at doses as low as 10-9 M. This low dose
was also found to be effective on thioglycollate-in-
duced macrophages (9).
Enzyme Secretion after Asbestos Exposure
in Vitro
The above experiments were all carried out with
cells plated directly on the fibrin substrate. Macro-
phages obtained from endotoxin-injected mice can al-
so secrete elevated PA levels after exposure to as-
bestos (or latex) in vitro (Table 4); the increase is pre-
dominantly extracellular (data not shown), indicating
that enzyme synthesis and secretion were tightly
coupled (9). There was no effect of asbestos (or latex)
on the secretion either of lysozyme or of two lyso-
somal enzymes, N-acetyl-f-D-glucosamindase and f3-
Table 3. Dose response for effect of dexamethasone on the
fibrinolytic activity due to asbestos feeding in vitro.
Radioactivity
Macrophages Dexamethasone released
(8 x 105)a concn,M at 24 hr,%
Endotoxin - 8
Endotoxin + asbestos (100jAg) - 34
Endotoxin + latex - 47
Endotoxin 10-9 1
Endotoxin + asbestos (100Jg) 10-9 12
Endotoxin + latex 10-9 13
Endotoxin 10-8 1
Entotoxin + asbestos (100 Jg) 10-8 4
Endotoxin + latex 10-8 4
Endotoxin 10-7 1
Endotoxin + asbestos (100 rig) 10-7 3
Endotoxin + latex 10-7 4
a Same experimental protocol as for Table 1.
galactosidase (Table 4). Further evidence in support
ofthe concept ofdifferential secretion control for PA
and for lysozyme and lysosomal enzymes is the fact
that dexamethasone and colchicine, drugs which
have a dramatic effect on the extracellular PA levels,
fail to alter the levels of lysozyme and lysosomal en-
zymes from macrophages when they are treated
with asbestos or latex particles.
Discussion
Previous studies (4, 10). have indicated that intra-
peritoneal injection of IARC chrysotile type B into
mice induces an inflammatory exudate and that
macrophages cultured from such exudates have ele-
vated levels of PA. It was also shown that perito-
neal macrophages when treated with the same as-
bestos fibers in vitro are stimulated to produce
more PA activity. The possible significance of mac-
rophage PA activity in inflammation has been out-
lined (9, 10). It has been shown above that as little
as 0.1 ,ug of the asbestos fibers can raise the PA ac-
tivity of endotoxin-primed mouse peritoneal macro-
phages. It is tempting to speculate that, since the in
vitro responses resemble those found with latex
particles, it is phagocytosis of the asbestos fibers
which results in the heightened protease activity.
However, until a quantitative analysis of fiber up-
take is made, such a conclusion is unwarranted, par-
ticularly as other agents, such as phorbol esters (7,
8), concanavalin A (7) lymphokines (6) and colony-
stimulating factors (14), which are presumably not
acting via a phagocytic pathway, can all stimulate
macrophage PA activity.
The enhanced PA activity is suppressed by anti-
inflammatory glucocorticoids. It might be profitable
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Table 4. Effect ofdrugs on secretion of plasminogen activator,
lysozyme and lysozomal enzymes after adding asbestos and latexin vitro.
N-Acetyl-p-glucos- P-Galactosidase
Lysozyme aminidase secreted secreted
Cell Secreted plasminogen secreted, Mmole/min/mg j*mole/min/mg
Macrophages Drug added protein/dish, activator units/mg pg/mg cell cell protein cell protein
(2 x 106)a (10-7M) tig cell protein protein ( x 1O2) 0/0 (x 103) 0/0
Endotoxin - 130 620 17.6 6.0 40 3.8 46
Endotoxin
+ asbestos - 190 2380 17.4 8.1 47 4.1 44
(100 Mg)
Endotoxin
+ latex - 250 2430 15.8 4.4 36 2.0 26
Endotoxin Dexamethasone 130 240 18.7 8.0 58 4.6 56
Endotoxin
+ asbestos Dexamethasone 210 110 16.3 7.3 59 3.5 51
(100 Mg)
Endotoxin
+ latex Dexamethasone 250 280 11.5 3.6 29 1.8 24
Endotoxin Colchicine 90 140 14.6 10.0 56 4.1 50
Endotoxin
+ asbestos Colchicine 100 210 14.6 11.1 75 4.1 69
(100 Mg)
Endotoxin
+ asbestos Colchicine 150 310 10.2 8.3 60 3.4 48
a Peritoneal cells were cultured in DB containing 5% FBS for 24 hr. The cells were then fed asbestos or latex for 2 hr at37°C and
then, after washing, placed in DB containing 0.05% LH in the presence or absence of the drug. CM and cell lysates were collected
after 48 hr.
if more were known about how glucocorticoids are
working in this context; perhaps these drugs are in-
ducing a "macrocortin-like" molecule which has been
proposed to account for the manner in which they
suppress cellular prostaglandin production (8,15). It
is again worth noting that, for macrophages, lyso-
zyme and two lysosomal enzymes activities appear
to be under different regulatory control to the PA
activity.
Studies of carcinogenesis by various forms of
asbestos, with and without hydrocarbon carcino-
gens, have shown that chrysotile can augment con-
siderably the number of malignant tumors produced
by benzo[a]pyrene (16,17): these studies and others
have suggested that asbestos fibers can function as
cocarcinogens (promoters). Interestingly, we have
shown that the tumor promoter in skin, namely, 12-
O-tetradecanoyl-phorbol-13-acetate (TPA), and asbes-
tos fibers, elicit similar acute inflammatory re-
sponses in rabbit skin (18) and, as mentioned above,
can both increase the PA activity of macrophages.
We have suggested that vascular alterations due to
an inflammatory reaction to both asbestos fibers and
to TPA ought to be considered in any analysis ofthe
development of neoplasms resulting from their ac-
tion(8,18).
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